Zimmer Biomet Holdings, Inc. Website

Zimmer Biomet Holdings, Inc.

NYSE-ZBH

Basic

  • Market Cap

    $22.36B

  • EV

    $27.98B

  • Shares Out

    205.73M

  • Revenue

    $7,452.4M

  • Employees

    18,000

Margins

  • Gross

    71.88%

  • EBITDA

    33.19%

  • Operating

    20.33%

  • Pre-Tax

    13.36%

  • Net

    12.93%

  • FCF

    11.96%

Returns (5Yr Avg)

  • ROA

    1.74%

  • ROTA

    6.48%

  • ROE

    3.23%

  • ROCE

    6.18%

  • ROIC

    5.59%

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • P/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

    $133.88

  • P/E

  • PEG

  • EV/Sales

  • EV/EBITDA

  • P/FCF

Financial Health

  • Cash

    $393M

  • Net Debt

    $5,610.8M

  • Debt/Equity

    0.48

  • EBIT/Interest

    7.44

Growth (CAGR)

  • Rev 3Yr

    2.89%

  • Rev 5Yr

    -1.14%

  • Rev 10Yr

    4.84%

  • Dil EPS 3Yr

    19.15%

  • Dil EPS 5Yr

    25.04%

  • Dil EPS 10Yr

    0.39%

  • Rev Fwd 2Yr

    4.77%

  • EBITDA Fwd 2Yr

    6.58%

  • EPS Fwd 2Yr

    7.19%

  • EPS LT Growth Est

    7.15%

Dividends

  • Yield

  • Payout

    20.68%

  • DPS

    $0.96

  • DPS Growth 3Yr

  • DPS Growth 5Yr

  • DPS Growth 10Yr

    1.59%

  • DPS Growth Fwd 2Yr

    0.67%

Select a metric from the list below to chart it

Dec '14

Dec '15

Dec '16

Dec '17

Dec '18

Dec '19

Dec '20

Dec '21

Dec '22

Dec '23

LTM

Dec '24 (E)

Dec '25 (E)

Dec '26 (E)

Total Revenues

7,982.2

6,127.5

6,827.3

6,939.9

7,394.2

7,452.4

Total Revenues % Chg.

0.6%

-23.2%

11.4%

1.6%

6.5%

4.8%

Cost of Goods Sold, Total

2,198.7

1,824.3

1,960.4

2,019.5

2,083.8

2,095.3

Gross Profit

5,783.5

4,303.2

4,866.9

4,920.4

5,310.4

5,357.1

Selling General & Admin Expenses, Total

3,278.6

2,524.4

2,626.4

2,667.6

2,793

2,815.8

R&D Expenses

449.3

322.8

435.8

406

458.7

456.2

Amortization of Goodwill and Intangible Assets

584.3

512.1

529.5

526.8

561.5

570.2

Other Operating Expenses

82.4

50.9

52.8

33.8

Other Operating Expenses, Total

4,394.6

3,410.2

3,644.5

3,634.2

3,813.2

3,842.2

Operating Income

1,388.9

893

1,222.4

1,286.2

1,497.2

1,514.9

Interest Expense, Total

-226.9

-212.1

-208.4

-164.8

-201.2

-203.7

Interest And Investment Income

Net Interest Expenses

-226.9

-212.1

-208.4

-164.8

-201.2

-203.7

Currency Exchange Gains (Loss)

-14.4

-12.2

-5.5

-20.8

26

49.8

Other Non Operating Income (Expenses)

-2.9

13.7

1.7

-135.4

-59.5

-90.8

EBT, Excl. Unusual Items

1,144.7

682.4

1,010.2

965.2

1,262.5

1,270.2

Restructuring Charges

-50

-107.2

-125.7

-191.6

-151.9

-234.5

Merger & Related Restructuring Charges

0.9

Impairment of Goodwill

-470

-289.8

Gain (Loss) On Sale Of Investments

Gain (Loss) On Sale Of Assets

Asset Writedown

In Process R&D Expenses

-70.1

-33

-16.3

-3

Legal Settlements

-52.7

-166

-201

-65.9

-21.6

-19.3

Other Unusual Items

-66.1

-11.4

-168.2

-11.4

-21.7

-21.7

EBT, Incl. Unusual Items

905.8

-105.2

499

403.5

1,067.3

995.6

Income Tax Expense

-225.7

-96

53.5

112.3

42.2

30.4

Earnings From Continuing Operations

1,131.5

-9.2

445.5

291.2

1,025.1

965.2

Earnings Of Discontinued Operations

-128.2

-43.4

-58.8

Minority Interest

0.1

-1.5

-0.5

-1

-1.1

-1.3

Net Income

1,131.6

-138.9

401.6

231.4

1,024

963.9

Net Income to Common Incl Extra Items

1,131.6

-138.9

401.6

231.4

1,024

963.9

Net Income to Common Excl. Extra Items

1,131.6

-10.7

445

290.2

1,024

963.9

Total Shares Outstanding

206

207.6

209

209

205.6

205.7

Weighted Avg. Shares Outstanding

205.1

207

208.6

209.6

208.7

207.7

Weighted Avg. Shares Outstanding Dil

206.7

207

210.4

210.3

209.7

208.7

EPS

5.5

-0.7

1.9

1.1

4.9

4.6

EPS Diluted

5.5

-0.7

1.9

1.1

4.9

4.6

EBITDA

2,395

1,791.4

2,160.1

2,212.6

2,448.9

2,473.4

Effective Tax Rate

-24.9%

91.3%

10.7%

27.8%

4%

3.1%